Normal UA Hyperuricemia p
MS (n=239) 8.91 ± 4.77 7.48 ± 4.27 0.017
Men(n=141) 9.31 ± 4.98 7.20 ± 4.54 0.009
<60 year(n=75) 9.98 ± 5.78 7.12 ± 4.49 0.019
≥60 year(n=66) 8.74 ± 4.19 7.30 ± 4.69 0.192
Women(n=98) 8.42 ± 4.57 8.29 ± 3.63 0.873
<60 year(n=42) 9.48 ± 4.43 8.53 ± 2.60 0.391
≥60 year(n=56) 7.36 ± 4.52 8.17 ± 4.07 0.485
NMS (n=376) 9.25 ± 4.34 8.44 ± 4.26 0.094
Men(n=190) 8.30 ± 4.73 7.87 ± 4.18 0.534
<60 year(n=92) 8.31 ± 5.07 7.92 ± 4.06 0.698
≥60 year(n=98) 8.30 ± 4.48 7.80 ± 4.42 0.621
Women(n=186) 10.16 ± 3.72 9.10 ± 4.29 0.091
<60 year(n=102) 10.59 ± 3.53 9.80 ± 4.88 0.376
≥60 year(n=84) 9.53 ± 3.92 8.54 ± 3.74 0.261
Controls(n=87) 12.12 ± 4.28 11.75 ± 5.28 0.747
NMS:Hypertensives without Metabolic Syndrome; MS:Hypertensives with Metabolic Syndrome.
Table 2: Comparison of FMD between hypertentives with hyperuricemia and without hyperuricemia.